Showing results (51-60 of 586) with videos related to
Sort By:
Pageof 59
ESC Heart Failure|October 29, 2019
Open access efforts begin to bloom: ESC Heart Failure gets full attention and first impact factorStefan D Anker, Stephan von Haehling, Zoltan PappExpert Opinion on Pharmacotherapy|May 26, 2010
Losartan: the dose does itWolfram Doehner, Stephan von Haehling, Stefan D AnkerExpert Opinion on Pharmacotherapy|January 25, 2021
An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexiaGuilherme Wesley Peixoto Da Fonseca, Stephan von HaehlingHeart Failure Reviews|March 26, 2003
Statins and the role of nitric oxide in chronic heart failureStephan von Haehling, Stefan D Anker, Eberhard BassengeJournal of Cachexia, Sarcopenia and Muscle|March 29, 2019
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia ConferenceNicole Ebner, Stefan D Anker, Stephan von HaehlingJournal of Cachexia, Sarcopenia and Muscle|February 13, 2020
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia ConferenceNicole Ebner, Stefan D Anker, Stephan von HaehlingInternational Journal of Cardiology|January 16, 2009
Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markersMitja Lainscak, Stephan von Haehling, Stefan D AnkerIndian Heart Journal|April 9, 2016
Sleep-disordered breathing and cardiovascular diseaseStefan D Anker, Stephan von Haehling, Robin GermanyHeart Failure Clinics|November 19, 2019
Cardiac Cachexia Revisited: The Role of Wasting in Heart FailureMiroslava Valentova, Stefan D Anker, Stephan von HaehlingExpert Opinion on Investigational Drugs|July 25, 2006
Toll-like receptor modulation in cardiovascular disease: a target for intervention?Gábor Földes, Stephan von Haehling, Stefan D AnkerPageof 59